With a market capitalization of $297.3 billion, Morgan Stanley (MS) is a leading global financial services firm headquartered in New York City, providing investment banking, wealth management, institutional securities, and asset management services to corporations, governments, institutions, and individuals worldwide. Founded in 1935, the company has grown into one of Wall Street’s most influential banking institutions, with operations spanning more than 40 countries.
Over the past year, MS stock has been on a ride, posting a 58.2% gain, outpacing the broader S&P 500 Index ($SPX), which rose by 28.5% during the same period. In 2026, MS stock has surged by 6.6%, surpassing the broader Index’s 6% increase during the same stretch.
More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.
Narrowing the focus, MS has also outperformed the State Street Financial Select Sector SPDR Fund’s (XLF) 4.4% return over the past year and 5.8% year-to-date fall.
www.barchart.com On Apr. 15, Morgan Stanley released its FY2026 Q1 earnings, and its shares jumped 4.5%. Driven by surging trading activity, a rebound in investment banking, and continued strength in wealth management, the bank posted record quarterly net revenue of $20.56 billion, up 16% year over year. Its earnings per share rose 31.9% from the year-ago quarter to $3.43, comfortably beating Wall Street expectations.
Morgan Stanley’s Institutional Securities division was the standout performer, delivering record revenue of $10.72 billion, up 19.3% year over year. Investment banking revenue surged 35.7% year over year to roughly $2.11 billion, driven by a major rebound in M&A advisory activity and stronger underwriting fees. Trading operations were exceptionally strong amid heightened market volatility. Equity trading revenue soared 24.7% to a record $5.15 billion, benefiting from strong client activity and higher derivatives trading volumes.
For the fiscal year 2026, ending in December, analysts anticipate MS to achieve EPS growth of 16.1%, reaching $11.85 on a diluted basis. Notably, Morgan Stanley has consistently beaten consensus estimates over the past four quarters.
Among 26 analysts covering MS stock, the consensus rating is a "Moderate Buy," comprising ten "Strong Buy" ratings, two "Moderate Buys," and 14 "Holds."
www.barchart.com The current analyst sentiment is slightly more bullish than a month ago, when MS had a total of seven "Strong Buy" ratings.
On Apr. 16, Barclays analyst Jason Goldberg raised his price target on Morgan Stanley to $230 from $219 while reiterating an “Overweight” rating, citing stronger-than-expected performance in the bank’s trading and wealth management businesses following its solid Q1 results.
The mean price target of $203.64 represents a 7.6% premium to MS’ current price levels. Meanwhile, the Street-high price target of $231 suggests a potential upside of 22.1%.
On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart
Positioning for a Big Move: SBUX Long Straddle Trade Idea Nasdaq Futures Rally on Upbeat AMD Earnings and U.S.-Iran Peace Deal Optimism As American Water Works Hikes Its Dividend, Consider Buying AWK Stock in May Pinterest Stock Skyrockets on Better-Than-Expected Earnings. Here's Why It's Not Too Late to Buy